It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Diabetes, hypertension, obesity, glaucoma, etc. are severe and common retinopathy diseases today. Early age detection and diagnosis of these diseases can save human beings from many life threats. The retina's blood vessels carry details of retinopathy diseases. Therefore, feature extraction from blood vessels is essential to classify these diseases. A segmented retinal image is only a vascular tree of blood vessels. Feature extraction is easy and efficient from segmented images. Today, there are existing different approaches in this field that use RGB images only to classify these diseases due to which their performance is relatively low. In the work, we have proposed a model based on machine learning that uses segmented retinal images generated by different efficient methods to classify diabetic retinopathy, glaucoma, and multi-class diseases. We have carried out extensive experiments on numerous images of DRIVE, HRF, STARE, and RIM-ONE DL datasets. The highest accuracy of the proposed approach is 90. 90 %, 95. 00 %, and 92. 90 % for diabetic retinopathy, glaucoma, and multi-class diseases, respectively, which the model detected better than most of the methods in this field.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




